Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.700
-0.060 (-3.41%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Pyxis Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 107 | 72 | 93 | 80 | 47 | 353 | |
| Market Cap Growth | 91.14% | -22.81% | 16.32% | 70.77% | -86.78% | - | |
| Enterprise Value | 59 | 14 | -32 | -32 | -136 | 414 | |
| Last Close Price | 1.70 | 1.15 | 1.56 | 1.80 | 1.34 | 10.97 | |
| PS Ratio | 7.71 | 5.17 | 5.75 | - | - | - | |
| PB Ratio | 2.00 | 1.34 | 0.77 | 0.63 | 0.29 | 1.35 | |
| P/TBV Ratio | 2.00 | 1.34 | 0.79 | 0.79 | 0.29 | 1.35 | |
| EV/Sales Ratio | 4.23 | 1.04 | - | - | - | - | |
| Debt / Equity Ratio | 0.35 | 0.35 | 0.17 | 0.17 | 0.12 | 0.00 | |
| Net Debt / Equity Ratio | -0.90 | -0.90 | -0.88 | -0.78 | -1.00 | -1.05 | |
| Net Debt / EBITDA Ratio | 0.62 | 0.62 | 1.71 | 1.25 | 1.31 | 3.98 | |
| Net Debt / FCF Ratio | 0.76 | 0.76 | 1.84 | 1.26 | 1.68 | 7.66 | |
| Asset Turnover | 0.11 | 0.11 | 0.10 | - | - | - | |
| Quick Ratio | 3.20 | 3.20 | 7.18 | 4.63 | 5.69 | 14.69 | |
| Current Ratio | 3.41 | 3.41 | 7.49 | 4.84 | 5.90 | 14.90 | |
| Return on Equity (ROE) | -91.44% | -91.44% | -62.76% | -51.51% | -57.19% | -56.78% | |
| Return on Assets (ROA) | -41.14% | -41.14% | -24.77% | -26.10% | -31.41% | -30.03% | |
| Return on Capital Employed (ROCE) | -116.30% | -116.30% | -47.00% | -54.30% | -68.70% | -26.70% | |
| Earnings Yield | -74.54% | -111.20% | -83.36% | -92.53% | -258.50% | -21.50% | |
| FCF Yield | -59.46% | -88.70% | -62.42% | -97.10% | -205.00% | -10.15% | |
| Buyback Yield / Dilution | -6.33% | -6.33% | -46.46% | -20.80% | -288.93% | -724.14% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.